MHTX — Manhattan Scientifics Balance Sheet
0.000.00%
- $0.06m
- $1.14m
Annual balance sheet for Manhattan Scientifics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.261 | 0.353 | 0.232 | 0.175 | 0.067 |
Net Total Receivables | 0.3 | 0.3 | 0.3 | 0 | — |
Prepaid Expenses | |||||
Total Current Assets | 0.574 | 0.665 | 0.547 | 0.189 | 0.069 |
Net Property, Plant And Equipment | 0.004 | 0.006 | 0.004 | 0.001 | 0 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2.23 | 6.85 | 3.45 | 1.03 | 0.316 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.09 | 1.01 | 1.36 | 1.67 | 2.12 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.17 | 1.12 | 1.36 | 1.67 | 2.12 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.053 | 5.73 | 2.09 | -0.637 | -1.8 |
Total Liabilities & Shareholders' Equity | 2.23 | 6.85 | 3.45 | 1.03 | 0.316 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |